H

SEC EDGAR - Form 4 insider activity

Halozyme Therapeutics, Inc. $HALO

Tracked equity - 4 filings indexed by Nortis

Nortis signal thesis

Cluster activity detected. Review whether the filings are open-market trades or routine compensation events.

0

OM buys - 90d

1

OM sells - 90d

3

Routine filings

4

Cluster filings

$368.2K

Largest trade

28/100

Avg signal score

Filing tape

Recent filings

Last 30d: 4
Option ExerciseCLUSTERRoutine 15/100
filed 2026-10-08
THCEO

Torley Helen - Director, PRESIDENT AND CEO - $368.2K

Option exercises are often compensation mechanics rather than a direct market view; what happens to the shares next matters more. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Grant / AwardCLUSTERRoutine 15/100
filed 2026-10-08
CBBoard

Connaughton Bernadette - Director - -

This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Grant / AwardCLUSTERRoutine 15/100
filed 2026-10-02
DMBoard

Daly James M - Director - -

This is compensation-related stock, not a purchase decision - it should not be read as an open-market buy. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing
Open-market SellCLUSTERNotable 65/100
filed 2026-10-02
PLBoard

Posard Matthew L. - Director - $78.2K

Insiders sell for many reasons (diversification, tax, personal); size and clustering matter more than a single sale. It is part of a cluster (3+ insiders within 7 days), which is generally more notable than an isolated filing.

View source filing